The CF Animal Imaging Core is proposed to provide researchers with the state-of-the-art facilities and services for in vivo imaging. The Core aims to use its existing clinical and preclinical imaging research infrastructure to present efficient and cost-effective imaging services to basic scientists and clinicians for Cystic Fibrosis research. The CF Animal Imaging Core will expand on the structure that facilitates interaction across departments and across schools in the university, bringing together researchers with a shared purpose of in-vivo analysis of underlying physiology of onset, progression, treatment and therapeutic assessment for disease. The advent of dedicated small animal imaging systems allows the integration of in vivo physiologic measurements with microscopic measurements of structure as well as cellular and genetic characterization of metabolic activities in animal models of CF. This approach provides a wealth of new information in elucidating the complex relationship between structure, energetics, and function in genetically manipulated animal models that have been used widely in CF research. These preclinical imaging capabilities are in addition to the clinical imaging research facilities available within Imaging Core / Department of Radiology. Therefore, the Animal Imaging Core efficiently provides the complete range of imaging services from basic preclinical research to translational imaging research to full clinical analysis in support of the CF Center at Case Western Reserve University and University Hospitals of Cleveland. Although this Core has been named the Animal Imaging Core to distinguish it from the Cell Imaging Core, please note that human imaging capabilities are also available through this Core in addition to advanced imaging of mice and other animal models.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK027651-26
Application #
7797508
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
26
Fiscal Year
2009
Total Cost
$227,248
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Lai, Nicola; M Kummitha, China; Rosca, Mariana G et al. (2018) Isolation of mitochondrial subpopulations from skeletal muscle: Optimizing recovery and preserving integrity. Acta Physiol (Oxf) :e13182
Donnola, Shannon B; Dasenbrook, Elliott C; Weaver, David et al. (2017) Preliminary comparison of normalized T1 and non-contrast perfusion MRI assessments of regional lung disease in cystic fibrosis patients. J Cyst Fibros 16:283-290
Darrah, Rebecca; Nelson, Rebecca; Damato, Elizabeth G et al. (2016) Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function. Biol Res Nurs 18:498-504
VanDevanter, Donald R; Morris, Nathan J; Konstan, Michael W (2016) IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. J Cyst Fibros 15:372-9
VanDevanter, D R; Flume, P A; Morris, N et al. (2016) Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis. J Cyst Fibros 15:783-790
Jiang, Kai; Jiao, Sen; Vitko, Megan et al. (2016) The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response. J Cyst Fibros 15:34-42
Bruscia, Emanuela M; Bonfield, Tracey L (2016) Cystic Fibrosis Lung Immunity: The Role of the Macrophage. J Innate Immun 8:550-563
Hsu, Daniel; Taylor, Patricia; Fletcher, Dave et al. (2016) Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation. Infect Immun 84:2410-21
Rymut, Sharon M; Kampman, Claire M; Corey, Deborah A et al. (2016) Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol 311:L317-27
Than, B L N; Linnekamp, J F; Starr, T K et al. (2016) CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 35:4179-87

Showing the most recent 10 out of 445 publications